Using the HER2 positive human breast cancer cells BT474 and SKBR3 as in vitro model systems and nude mice with BT474 xenografts as an in vivo model, this conjugate was comprehensively characterized, and its efficacy was evaluated and compared to free DOX. This evidence concerns the gene ERBB2 and breast carcinoma.